Navigation Links
Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
Date:10/27/2009

ica, Inc. ($27.2M). (4) To exclude costs related to the CIMA restructuring. (5) To exclude charges related to the settlement of investigations by the Offices of the Attorney General of Connecticut and Massachusetts and estimated relator attorney fees. (6) To exclude non-cash interest expense associated with our convertible debt ($40.5M in 2009; $36.3M in 2008) and accrued interest related to the agreement in principle reached with the U.S. Attorney's Office in Philadelphia ($11.3M in 2008). (7) In 2009, to exclude the following gains and losses related to the acquisition of Arana Therapeutics Limited: - $6.6M gain on pre-bid Arana holdings; - $2.8M loss on contingent consideration (90% ownership incentive payment); - $10.0M gain on the excess of net assets over consideration; - $19.0M gains on foreign exchange derivative instruments; - $5.6M foreign exchange gain on Australian Dollar acquisition funds; and - $1.6M dividend income related to our initial purchase of Arana shares. (8) To exclude charges related to the deconsolidation of Acusphere ($9.3M), the acquisition of worldwide license rights related to LUPUZOR from ImmuPharma ($30.0M), license rights for bendamustine hydrochloride in China and Hong Kong ($0.8M) and license rights to certain of XOMA Ltd.'s proprietary antibody library materials ($6.0M) in 2009 and the license of Acusphere HDDS technology for use in oncology therapeutics in 2008. (9) In 2009 to exclude the portion of non-cash charges related to our acquisition of Arana Therapeutics Limited that are reflected in adjustments (7) above but do not affect net income because they are attributed to noncontrolling interests. (10) To reflect the tax effect of pre-tax adjustments at applicable tax rates and certain other tax adjustments primarily related to the tax benefits for the settlement
'/>"/>
SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
3. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
4. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
5. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
6. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
7. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
8. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
9. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
10. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
11. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 18, 2014 Capnia, Inc. (NASDAQ: ... of medical diagnostics based on its proprietary Sensalyze™ ... today announced financial results for the third quarter ... "Following the completion of our initial public ... maximize the recently initiated CoSense® commercial launch," said ...
(Date:12/19/2014)... -- Baptist Health Lexington is the first facility in ... Fibrillation with Electrophysiology Services (EPS) Accreditation status from the Society ... the most common cardiac arrhythmia and has become recognized as ... stroke and possible death. More than 5 million patients in ... and the numbers are rapidly increasing as the population ages. ...
(Date:12/19/2014)... 18, 2014   Aratana Therapeutics, Inc . ... focused on the licensing, development and commercialization of ... results from its pivotal field study of AT-001 ... in dogs with osteoarthritis.  In the study, dogs ... that were statistically significant compared to placebo (p<0.05) ...
Breaking Medicine Technology:Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
... plc , (LSE: SHP, Nasdaq: SHPGY ), the ... and Drug Administration (FDA) approved the use of once-daily ... for the treatment of attention deficit hyperactivity disorder (ADHD) in ... a total treatment program. The approval is based on results ...
... YORK, Feb. 28, 2011 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... the Company,s Chief Executive Officer, will be presenting at ... Conference (New York, NY)Wednesday, March 2, 201111:00am ETCowen & ... MA)Monday, March 7, 2011 4:45pm ETROTH 23rd Annual OC ...
Cached Medicine Technology:FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 2FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 3FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 4FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 5FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 6Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations 2
(Date:12/19/2014)... (PRWEB) December 19, 2014 After a ... performer is again returning to the stage to entertain ... husband for concert performances, and the successful tour has ... originally announced. , Visit Ticketability.com for ... newly-announced Detroit shows at fair prices. , Music fans ...
(Date:12/19/2014)... new study suggests a possible link between certain menopause ... sweats -- and higher rates of hip fractures and ... affecting about 60 percent of women. The hormonal changes ... then face a higher risk of weakened bones and ... or severe menopausal symptoms are more likely to have ...
(Date:12/19/2014)... -- Prostaglandin analogue eye drops -- a common form ... vision loss in patients with the eye disease, a ... Garway-Heath, of the Moorfields Eye Hospital and UCL Institute ... 500 people newly diagnosed with open-angle glaucoma -- the ... the leading causes of blindness. About 45 million ...
(Date:12/17/2014)... 2014 This prestigious award is ... have made outstanding and innovative contributions to the ... of private practice physical therapy by the Private ... , On behalf of Performance Physical Therapy, Michelle ... of Performance accepted the award at the Private ...
(Date:12/17/2014)... December 17, 2014 Now in its ... the best of the best in senior living and ... only given to communities and agencies that have received ... site. Of the nearly 100,000 providers currently listed on ... of the SeniorAdvisor.com Best of 2015 Awards are located ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Severe Hot Flashes During Menopause May Raise Hip Fracture Risk Later: Study 2Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 3
... School in Minneapolis said that a protein complex in the ... ,This could be a new target for drug designing to ... genetically engineered mice that suffered from memory loss similar to ... million people worldwide suffer from Alzheimer's disease. It is the ...
... conducted which proved that a simple measuring tape is an important ... index (BMI). // BMI is the composite measure of weight and ... the world. The findings were that in men, the risk of ... increase in waist size. On the other hand women, showed an ...
... Health reports that deaths from coronary artery heart disease ... ,Mid 1980s. // This is attributed mainly to lifestyle changes, ... from coronary artery disease in Ireland, dropped by almost 47%, ... this meant nearly 3800 fewer deaths when compared to figures ...
... speakers have raised an appeal to clerics to increase ... in the country.// ,This workshop titled “AIDS is ... the provincial AIDS Control Programme in collaboration with World ... Health Minister Inayatullah Khan said that religious scholars in ...
... has said it will be increasing the salary of the ... elderly people by 10 percent from next year. Around ?7 ... // ,The announcement said that the community dentists would ... have a long and important tradition as an essential part ...
... Institute of Health and Welfare has said that measures ... HIV-AIDS, account for large sums in public health expenditure. ... healthy community and according to statistics, these spending are ... ,In 2002-03, about $77 million was expended on ...
Cached Medicine News:Health News:Increase in Waist Size Contributes To Increased Risk of Heart Disease 2
... allows the user to quickly and accurately count ... digital counting or manual counting. An optional 1.5X ... magnification to 3.0X. The adjustable focusing rod allows ... lowered. The lens also rotates a full 360 ...
The Accucount 2000 is designed to automatically count microscopic objects in a field displaying totals on a highly visible digital readout....
The Accucount 1000 is designed to automatically count macroscopic objects in a field displaying totals on a highly visible digital readout....
... The CA-1000 counts a Petri dish ... on the optical characteristics of the colonies ... The CA-1000 is equipped with three types ... are lighter or darker than the agar ...
Medicine Products: